fda retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation The Thriving Black Market for
Description
Four weeks per step is a guide, not a deadline

It tells your brain you're full, slows digestion so you stay satisfied longer, and helps regulate blood sugar levels

Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-B in human osteoarthritis chondrocytes

A new randomized clinical trial just published in JAMA Psychiatry tested semaglutide (a GLP-1 agonist) in people with schizophrenia, prediabetes, and obesity who were taking antipsychotics
Pract Diabetes
